AAV-mediated VEGF-C156S delivery

AAV-mediated VEGF-C156S delivery has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 31, 2026: “Raising a fat-cell protein reversed diet-induced obesity in mice”.

Intervention

1 paper studies it1 findingUpdated Oct 30, 2026

1 new paper in 30 daysSee all 1

1 lab

Animals1

What did studies of AAV-mediated VEGF-C156S delivery find?

Studies of AAV-mediated VEGF-C156S delivery measured 1 outcome; the most studied are high-fat diet-induced obesity (1 study).

High-fat diet-induced obesity

downin mice1

1 study

AAV-mediated VEGF-C156S delivery decreases high-fat diet-induced obesity in mice (adipocyte-specific Pdgfd knockout under high-fat diet).
“delivery of an engineered VEGF-C variant (VEGF-C156S) successfully suppressed HFD-induced obesity in young adipocyte-PDGF-D knockout mice.”
Animalsadipocyte-specific Pdgfd knockout under high-fat dietAAV-mediated delivery of VEGF-C156S
Raising a fat-cell protein reversed diet-induced obesity in mice
Frontiers in endocrinologyOct 30, 2026

Latest

1 paper in 12 months

Frontiers in EndocrinologyOct 30

Raising a fat-cell protein reversed diet-induced obesity in mice

In genetically altered middle-aged mice, increasing a protein in fat cells restored lymphatic function and reversed severe obesity caused by a high-fat diet.In genetically altered middle-aged mice, increasing a protein in fat cells restored lymphatic function and reversed severe obesity caused by a high-fat diet.

Accepted, not yet published: mouse studyMechanisms

Paper

AAV-mediated VEGF-C156S delivery

What did studies of AAV-mediated VEGF-C156S delivery find?

Latest

Raising a fat-cell protein reversed diet-induced obesity in mice

Related